STG Inhibitors
STG inhibitors are a class of chemical compounds that specifically target and inhibit the activity of the STG protein family, which is involved in various cellular processes, including signal transduction and cell regulation. STG, short for Stathmin-like proteins, plays a crucial role in regulating microtubule dynamics within the cell. Microtubules are essential for a wide range of cellular functions, such as cell division, intracellular transport, and maintaining the cell's structure. STG proteins are known to destabilize microtubules by binding to tubulin, the building block of microtubules, and preventing its polymerization. By inhibiting the function of STG proteins, these compounds alter the normal assembly and disassembly of microtubules, potentially disrupting processes like cell division, migration, and intracellular trafficking.
The mechanism of action of STG inhibitors typically involves binding to functional domains of the STG proteins, preventing them from interacting with tubulin or altering their ability to regulate microtubule dynamics. Some inhibitors may directly compete with tubulin for binding to STG, while others may induce conformational changes that reduce the ability of STG proteins to destabilize microtubules. By inhibiting STG proteins, these compounds interfere with cellular processes dependent on microtubule dynamics, such as mitosis, where precise control of microtubule assembly is critical for chromosome segregation. Research into STG inhibitors provides insights into the molecular mechanisms governing microtubule regulation and highlights the role of these proteins in maintaining cellular architecture. Understanding how STG proteins contribute to microtubule dynamics sheds light on the broader biological importance of cytoskeletal regulation in cellular function and homeostasis.
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $153.00 $396.00 | 113 | |
Staurosporine is a potent inhibitor of protein kinases. Given that STG is a signaling molecule, inhibition of upstream kinases that phosphorylate STG could inhibit its activation and subsequent signaling cascades. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 is a PI3K inhibitor. PI3K pathway can regulate a variety of proteins involved in signaling cascades. Inhibition of PI3K can lead to reduced phosphorylation and activation of proteins downstream, including STG. | ||||||
PP 2 | 172889-27-9 | sc-202769 sc-202769A | 1 mg 5 mg | $94.00 $227.00 | 30 | |
PP2 is an Src family kinase inhibitor. Src kinases can phosphorylate several downstream targets including proteins like STG, leading to their activation. Inhibiting Src kinases can prevent the activation of STG. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
PD98059 is an inhibitor of MEK, which is upstream of the MAPK/ERK pathway. The MAPK/ERK pathway is known to regulate various signaling proteins, potentially including STG. Inhibition of MEK can prevent the phosphorylation and activation of STG. | ||||||
U-0126 | 109511-58-2 | sc-222395 sc-222395A | 1 mg 5 mg | $64.00 $246.00 | 136 | |
U0126 is another MEK inhibitor that works similarly to PD98059. By inhibiting MEK, U0126 can prevent the activation of ERK and downstream proteins in the signaling pathways, possibly including STG. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
SB203580 is a p38 MAPK inhibitor. The p38 MAPK pathway can regulate stress responses and cytokine production. Inhibition of p38 MAPK can inhibit the function of proteins involved in these pathways, including STG. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
SP600125 is an inhibitor of JNK, which is involved in stress and apoptosis signaling pathways. JNK can phosphorylate various substrates that might interact with STG, thus inhibiting JNK can reduce STG function. | ||||||
NF449 | 627034-85-9 | sc-478179 sc-478179A sc-478179B | 10 mg 25 mg 100 mg | $203.00 $469.00 $1509.00 | 1 | |
NF449 is a potent and selective inhibitor of Gs-alpha, part of G-protein-coupled receptor signaling. By inhibiting Gs-alpha, the chemical can reduce cAMP levels, which could lead to the inhibition of proteins regulated by cAMP, including STG. | ||||||
Gö 6983 | 133053-19-7 | sc-203432 sc-203432A sc-203432B | 1 mg 5 mg 10 mg | $105.00 $299.00 $474.00 | 15 | |
Go6983 is a broad-spectrum protein kinase C inhibitor. Protein kinase C is involved in numerous signaling pathways that can phosphorylate and activate proteins such as STG. Inhibition of Protein kinase C can therefore inhibit STG function. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Wortmannin is a potent inhibitor of phosphoinositide 3-kinases. By inhibiting PI3Ks, wortmannin can prevent the activation of downstream signaling proteins, potentially including STG. | ||||||